QEHC Logo
ServicesCareersDIRECTIONSNewsNewsletterFind a provider
Imaging & Radiology at QEHC
Imaging & Radiology
Back
back
Imaging & Radiology
Key Clinics
diagnostic imaging clinic
services
Mammography
Bone Density Scan
X-Ray
Ultrasound
View all
Medical Care Services at QEHC
Medical Care
Back
back
Medical Care
Key Clinics
Diagnostic Imaging Clinic
Medical Specialists Clinic
Urgent Care Clinic (Super Clinic)
Primary Care Clinic
Family Medicine Clinic (MUHC)
Services
Audiology
Blood Tests
Dental Care
Diabetes Education
Endocrinology
Family Medicine
Internal Medicine
Laser Surgery
Medical Botox
Neurology
Urology
View all
Mental Health Services at QEHC
Mental Health
Back
back
Mental & Emotional Health
Art Therapy
Child Psychology
Counseling
Couples Therapy
Divorce & Family Mediation
Drama Therapy
Family Therapy
Music Therapy
Psychiatry
Psychology
Psychotherapy
View all
Alternative Therapy Services at QEHC
Alternative Therapy
Back
back
Alternative & Holistic Therapy
Acupuncture
Chinese Massage
Chiropractic
Homeopathy
Massotherapy
Naturopathy
Osteopathy
Reflexology
Reiki
View all
Communication
Other Services
Clinic

DOvEEgene Satellite Project

Detecting Ovarian and Endometrial Cancer Early Using Genomics
Medical

DOvEEgene - Detecting Ovarian and Endometrial Cancer Early Using Genomics - is a research test available to women between the ages of 45 and 75 who have not previously had surgery to remove their uterus. This research project was awarded a grant from Genome Canada and Genome Quebec in collaboration with the MUHC Foundation (Genomic Applications Partnership Program) to initiate final testing phase. The study is led by Dr. Lucy Gilbert, the Director of the Gynecology-Oncology Division at Montreal's Royal Victoria Hospital, Glen Site.

In the previous phase of the study, the DOvEEgene test was able to detect ovarian and/or endometrial cancer as early as stage 1 versus stage 3 or 4 with current methods. Early diagnosis is crucial because when ovarian cancer is diagnosed in its early stage, the survival rate is 93% versus 10-30% in advance stage (5 years survival rate means the percentage of women alive 5 years after initial diagnosis).

All women, symptomatic or asymptomatic, between the ages of 45 and 75 who have a uterus are eligible to participate in the DOvEEgene research study. The medical examinations and services are free for residents of Quebec with a valid RAMQ card as they are covered by the Régie de l'Assurance Maladie du Québec (RAMQ).

To learn more about the DOvEEgene study, eligibility, and to book an appointment, please visit https://doveegene.com/

In addition, you are most welcome to spread this news about the DOvEEgene clinic at the QEHC - increasing awareness of this great initiative can save lives.

Toll Free: 1-866-716-3267

Contact

DOvEEgene Satellite Project

Locale
2100 Marlowe Ave
Montreal, QC
H4A 3L5
Opening Hours
Phone Number
(514) 934-1934 ext. 44482
Fax Number
Email Address
doveegene@mcgill.ca
Book OnlineVisit Website

Services offered by

DOvEEgene Satellite Project

Covered by RAMQ
Covered by RAMQ
Referral Required
Referral Required
QEHC Logo
About
About UsSpace RentalJobs & VolunteeringNewsDonatePrivacy PolicyGovernance Policies
contact

2100, Marlowe Avenue
Montréal, Québec
H4A 3L5

DirectionsContact your Health ProviderBuilding AdministrationDigital Radiology Requisition Forms
Sign up for our newsletter
FacebookLinkedIn
Copyright Queen Elizabeth Health Complex 2025
Website design by Drea Gideon
Photography by HAVEN Creative Space